Anti-HIV-1 GP120 [b12 (MT12)]

AB02807-23.0-BT
ApplicationsELISA, Neutralisation/Blocking
Product group Antibodies
ReactivityVirus
Overview
- SupplierAbsolute Antibody
- Product NameAnti-HIV-1 GP120 [b12 (MT12)]
- Delivery Days Customer9
- Antibody SpecificityThis antibody binds CD4 binding site of the HIV-1 GP120.
- Application Supplier NoteBinding affinity of the Fab antibody and the IgG1 version towards HIV-1 gp120 was determined using ELISA (US5804440). This antibody is a potent neutralizer of HIV strains IIIB and MN. The IgG1 version of b12 antibody showed 50% neutralization titers of less than 40ng/ml for both IIIB and MN strain in a p24 reporter assay. b12 can neutralize about 75% of clade B strains of HIV-1 (those most common in North America), but it neutralizes less than 50% of other strains of HIV-1 found worldwide (PMID: 7973652). This antibody has also shown promise in complete protection against HIV-1 in hu-PBL-SCID mouse model by passive immunization. The in vivo protective dose against viral challenge was found to be 4.5-7mg/kg (PMID: 7662189). This antibody is also reported to neutralize HXBc2 HIV-1 strain (PMID: 7518527).
- ApplicationsELISA, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDb12 (MT12)
- HostRabbit
- IsotypeIgG
- Protein IDP03377
- Protein NameEnvelope glycoprotein gp160
- Scientific DescriptionThis chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format for improved compatibility with existing reagents assays and techniques.
- ReactivityVirus
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203